Amovir SRL
Amovir reported total assets of €1.20m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
By total assets for 2025, Amovir ranks in the top half of the 3,777 companies in its sector (NACE 7010) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Amovir shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amovir's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Amovir's financial analysis
- Solvency97.8%sector median: 53.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amovir
Amovir's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.815.496
- VAT number
- BE0894815496
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 28 Dec 2007
- Registered office
- 3640 Kinrooi
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Activities of head offices (NACE 7010001)
Amovir (SRL) has been based in Kinrooi since 2007, active in: activities of head offices. For 2025, it reports a net loss of 1,256 € and equity of €1.17m; its revenue is not published. Its solvency stands at 97.8%, above the median of its sector (53.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Amovir
Companies in the same business, of comparable size and area, outside its group.
- Gestion, Représentation, Participations et Finances Liège · balance sheet €1.20m
- Tandartsenkabinet de Clercq en Snick Dental practice care activities Oostrozebeke · balance sheet €1.20m
- Noyo Invest Rental and operating of own or leased real estate Ottignies-Louvain-la-Neuve · balance sheet €1.20m
- Bureau de Services Financiers, d' Assurances et d' Administration Development of building projects Somme-Leuze · balance sheet €1.20m
- Immo Miro Rental and operating of own or leased real estate Vosselaar · balance sheet €1.20m
- Decover Binding and related services Ixelles · balance sheet 955,975 €
- Schoenmakers International Other financial service activities, except insurance and pension funding n.e.c. Riemst · balance sheet €1.20m
- De Lint Vastgoed Activities of holding companies Oud-Turnhout · balance sheet €1.20m
Frequently asked questions about Amovir
What is the revenue of Amovir?
Amovir files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Amovir?
In Belgium, the VAT number is the company number prefixed with BE: BE0894815496 for Amovir, if the company is VAT-registered. Its company number (CBE) is 0894.815.496.
Where is the registered office of Amovir?
According to the CBE register, the registered office of Amovir is in 3640 Kinrooi.
What is the equity of Amovir?
At the close of the 2025 financial year, the equity of Amovir amounts to 1,171,444 €, a solvency of 97.8% of total assets.
Who manages Amovir?
The register lists 1 active mandates at Amovir. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Amovir within its sector?
By total assets for 2025, Amovir ranks in the top half of the 3,777 companies in its sector (NACE 7010) in Belgium that filed accounts for that financial year.
The full file of Amovir
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →